YZYan Zhang

Yan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yan Zhang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Bohui Xu

    School of Pharmacy, Nantong University, Nantong 226019, P.R. China

    1 shared publication
  • Dan Qiao

    Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan 030000, Shanxi, China; Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Taiyuan 030000, Shanxi, China

    1 shared publication
  • Han Yang

    Department of Pharmaceutics, School of Pharmacy, Nantong University, Nantong, 226001, PR China

    1 shared publication
  • Qifeng Zhang

    Department of Pharmaceutics, School of Pharmacy, Nantong University, Nantong, 226001, PR China

    1 shared publication
  • Qin-Yi Su

    Department of Rheumatology and Immunology the Second Hospital of Shanxi Medical University Taiyuan Shanxi China

    1 shared publication
  • Rong-Qi Li

    Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan 030000, Shanxi, China; Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Taiyuan 030000, Shanxi, China

    1 shared publication

Latest Publications

  • Open Access

    Gut microbiota dysbiosis in rheumatoid arthritis: a systematic review and meta-analysis

    by Qin-Yi Su, Yan Zhang, Dan Qiao, Xia Song, Yang Shi, Rong-Qi Li, Ying-Fang Zhang, Sheng-Xiao Zhang

    Background: Rheumatoid arthritis (RA) is an autoimmune joint disease with systemic manifestations. Emerging evidence implicates the gut microbiota in the pathophysiology of RA. However, the specific changes in the gut microbiota in RA patients remain poorly understood. Methods: We conducted a comprehensive search of PubMed, EMBASE, Web of Science, Cochrane Library, MEDLINE, Wanfang, VIP, CBM, and CNKI from the time the databases were created until October, 2023. To evaluate changes in α-diversity and the abundance of certain microbiota families in RA, standardized mean difference (SMD) and 95% confidence interval (CI) calculations were made. Results: Firstly, we evaluated the changes in α-diversity of gut microbes in patients with RA compared to healthy controls. Our analysis of 18 studies revealed a significant decrease in richness and evenness among RA patients. Importantly, the subgroup analysis suggested the decrease in α-diversity was more significant in treatment naïve patients rather than those who received anti-rheumatic medication. Additionally, in the subgroup analysis of 316 patients stratified by baseline disease activity, no significant differences in α-diversity were detected between groups. Discussion: Our analysis further evidence of altered α-diversity and the relative abundance of specific bacteria in RA. These findings contribute to our understanding of the role of gut microbiota dysbiosis in the pathogenesis of RA. Further research is warranted to elucidate the underlying mechanisms and explore the potential therapeutic implications of targeting the gut microbiota in RA management.


  • Retracted

    Retracted: siVEGF-Loaded Nanoparticle Uptake by Tumor-Associated Vascular Endothelial Cells for Hepatocellular Carcinoma

    by Bohui Xu, Yan Zhang, Han Yang, Tingting Liu, Youjia Lu, Yan Xu, Qifeng Zhang, Xingyu Li, Zhiqi Huang, Yuanyuan Zhang, et al.

    Aim: This study examined nanoparticle entry into tumor-associated vascular endothelial cells during transport to hepatocellular carcinoma cells and tumors. Materials & methods: siVEGF was loaded in...